MedDataX Logo

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

NCT ID: NCT01678170

Last Updated: 2015-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is going to evaluate the value of blood-oxygen functional imaging technology in the diagnosis of breast diseases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

blood-oxygen functional imaging technology diagnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female older than 18 years breast lump received breast ultrasound and mammography

Exclusion Criteria

* After core-needle biopsy or resection After neoadjuvant chemotherapy, radiotherapy or endocrine therapy
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tianjin Medical University Cancer Institute and Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peifang Liu, M.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Breast Imaging, Tianjin Medical University Cancer Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Breast Imaging, Tianjin Medical University Cancer Hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Peifang Liu, M.D.

Role: CONTACT

Phone: +86-22-23524536

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Peifang Liu, M.D.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIH-LPF-201205001

Identifier Type: -

Identifier Source: org_study_id